Approval · Notice of Compliance 18035 · 2016
JAMP-RISPERIDONE: Notice of Compliance 18035
Issued April 27, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18035
- Date
- April 27, 2016
- Company
- JAMP Pharma CorporationBoucherville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- RISPERDAL (Janssen Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| JAMP-RISPERIDONE | 02454319 | Dormant |
Medicinal ingredients
- RISPERIDONE 1 MG per ML